- Report
- September 2026
- 181 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 181 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 199 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 190 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 199 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 184 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- November 2026
- 378 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 179 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- August 2026
- 181 Pages
Global
From €3691EUR$3,950USD£3,083GBP
- Report
- February 2026
- 155 Pages
Global
From €4532EUR$4,850USD£3,786GBP
- Report
- March 2022
- 312 Pages
Global
From €6541EUR$7,000USD£5,464GBP
- Report
- September 2025
- 286 Pages
Global
From €4625EUR$4,950USD£3,864GBP
- Report
- February 2023
- 287 Pages
Global
From €2336EUR$2,500USD£1,951GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4625EUR$4,950USD£3,864GBP
- Report
- June 2025
- 100 Pages
United States
From €5560EUR$5,950USD£4,645GBP
From €5560EUR$5,950USD£4,645GBP
- Report
- June 2024
- 180 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- February 2024
- 187 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- March 2023
- 116 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- April 2026
- 90 Pages
India
From €4438EUR$4,750USD£3,708GBP

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence.
Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events.
Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more